IL7R and pancreatic ductal adenocarcinoma: Heo et al. indicated that the survival probability of pancreatic ductal adenocarcinoma patients with low IL-7R expression was modestly higher than that of patients with high IL-7R expression, as revealed by in silico analysis [52].